Debunked Episode 20: A Look at H-1B Visas in Healthcare, M&A Deals for Bitcoin and More
MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation…
Debunked Episode 20: A Look at H-1B Visas in Healthcare, M&A Deals for Bitcoin and More
MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed whether bitcoin would play a greater role in healthcare deals and the Trump administration’s mixed messages on autism and Tylenol. The post Debunked Episode 20: A Look at H-1B Visas in Healthcare, M&A Deals for Bitcoin and…
Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic
Pfizer Ventures led the Series B financing of Cartography Biosciences, whose lead program addresses a promising target for colorectal cancer. The startup’s drugs come from platform technologies that analyze data from healthy cells and cancer cells to identify cancer-specific targets. The post Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic…
KFF Health News’ ‘What the Health?’: Democrats Make This Shutdown About the ACA
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem
Success requires orchestrating an end-to-end experience that connects manufacturing, logistics, clinical sites, payers, and patients seamlessly. The companies that treat this orchestration as a strategic competency, rather than just operational logistics, will be best positioned to scale. The post Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem appeared first on MedCity News.
Phygital Healthcare Experiences? What Hospitals Can Learn from Retail’s CX Standards
Retail has shown what’s possible when human-centered technology is used to improve in-person experiences. Now it’s healthcare’s turn. The post Phygital Healthcare Experiences? What Hospitals Can Learn from Retail’s CX Standards appeared first on MedCity News.
‘Demon Copperhead’ Author Lays Foundation for Women in Appalachia To Beat Addiction
PENNINGTON GAP, Va. — On a Saturday evening in June, people of this rural region gathered at the historic Lee Theatre to celebrate the founding of Higher Ground Women’s Recovery Residence. Author Barbara Kingsolver opened the facility in January with royalties from her Pulitzer Prize-winning novel, “Demon Copperhead,” whose plot revolves around Appalachia’s opioid crisis….
Workers’ Wages Siphoned To Pay Medical Bills, Despite Consumer Protections
Stacey Knoll thought the court summons she received was a scam. She didn’t remember getting any medical bills from Montrose Regional Health, a nonprofit hospital, after a 2020 emergency room visit. So she was shocked when, three years after the trip to the hospital, her employer received court orders requiring it to start funneling a…
Hackensack Meridian Health Launches Trial of Canine-Powered Cancer Detection
Hackensack Meridian Health launched a clinical trial with Israeli startup SpotitEarly, which is developing a cancer test that combines AI with trained dogs to analyze patients’ breath. The study aims to validate this noninvasive approach alongside traditional screenings, potentially enabling earlier and more accessible cancer detection. The post Hackensack Meridian Health Launches Trial of Canine-Powered…
Visana Health Secures $24M for Women’s Health Clinic
Visana Health’s Series A round was led by Noro-Moseley Partners and included participation from The Cigna Group Ventures, Intermountain Ventures, Flare Capital Partners and Frist Cressey Ventures. The post Visana Health Secures $24M for Women’s Health Clinic appeared first on MedCity News.
Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to support potential expansion of the twice-daily pill to other immunological disorders. The post Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives appeared first on MedCity News.
